This is an old revision of this page, as edited by 88.106.28.18 (talk) at 14:24, 14 December 2022 (→Synthesis). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 14:24, 14 December 2022 by 88.106.28.18 (talk) (→Synthesis)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Chemical compound Pharmaceutical compoundClinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.044.121 |
Chemical and physical data | |
Formula | C12H11ClN6O2S2 |
Molar mass | 370.83 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Azosemide is a high-ceiling loop diuretic agent that was brought to market in 1981 by Boehringer Mannheim. As of 2015 it was available as a generic in some Asian countries.
Azosemide has been found as an adulterant in ketamine.
Synthesis
Chlorosulfonation of 2-fluoro-4-chloro-benzonitrile (1) followed by ammonolysis of the product gives 4-chloro-2-fluoro-5-sulfamoylbenzonitrile (2). Selective displacement of the fluoride leaving group by 2-aminomethylthiophene (3) gives PC68423892 (4). Treatment with sodium azide and hydrochloric acid leads to 1,3 addition of the elements of hydrazoic acid to the nitrile and the formation of a tetrazole ring. This yields the high ceiling diuretic agent azosemide (5).
References
- Sittig M (1988). Pharmaceutical Manufacturing Encyclopedia (PDF). Vol. 1. Noyes Publications. p. 122. ISBN 978-0-8155-1144-1. Archived from the original (PDF) on 2007-10-23.
- Bormann D (January 1980). "Diuretics". In Hess HJ (ed.). Annual Reports in Medicinal Chemistry. Vol. 15. Academic Press. pp. 100–105 (101). ISBN 978-0-08-058359-4.
- "International listings for azosemide". Drugs.com. Retrieved 23 July 2015.
- "Drug Checking Report 2011" (PDF). Energy Control. Retrieved 20 January 2022.
- DE1815922 idem A. Popelak et al., U.S. patent 3,665,002 (1972 to Boehringer, Mann.).
- Ansgar Dr Rer Nat Lerch, 4 More », DE2353388 (1975 to Boehringer Mannheim Gmbh).
- www.lookchem.com/Chempedia/Chemical-Technology/Organic-Chemical-Technology/18708.html
- KR20110129622
- 高朋, 习富刚, & 武乾刚, CN106749068 (2017 to KUNSHAN RIKITA PHARMACEUTICAL Co Ltd).
Diuretics (C03) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Sulfonamides (and etacrynic acid) |
| ||||||||
Potassium-sparing (at CD) |
| ||||||||
Osmotic diuretics (PT, DL) | |||||||||
Vasopressin receptor inhibitors (DCT and CD) | |||||||||
Other | |||||||||
Combination products | |||||||||
|
This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it. |